Autoantibodies in post-treatment Lyme disease and association with clinical symptoms

CONCLUSIONS: Several autoantibodies were found after Borrelia burgdorferi and SARS-CoV2 infection, although the prevalence was similar in those with persistent symptoms and those who returned to health. While our data show no difference in autoantibody prevalence across the four post-infectious states, we do not imply that autoantibodies are irrelevant in this setting. Rather, this study highlights the need for novel antibody discovery in larger cohorts of well-defined patient populations.PMID:38607687 | DOI:10.55563/clinexprheumatol/qcupkk

Source: Clinical and Experimental Rheumatology - April 12, 2024 Category: Rheumatology Authors: Marzieh Keshtkarjahromi Alison W Rebman Annukka A R Antar Yukari C Manabe Laura Gutierrez-Alamillo Livia A Casciola-Rosen John N Aucott John B Miller Source Type: research